Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta cir. bras ; 35(3): e202000304, 2020. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1130623

Résumé

Abstract Purpose To investigate the protective effect of rosmarinic acid (RA) in ovarian ischemia/reperfusion injury using biochemical, histopathological, and immunohistochemical methods. Methods Wistar female rats (n = 32) were randomly divided into four groups: control, ischemia, ischemia-reperfusion, and ischemia-reperfusion with RA. Rosmarinic acid was given at a dose of 50 mg/kg by oral gavage three hours after reperfusion. Malondialdehyde (MDA) levels and glutathione peroxidase (GSH-Px) activities were determined in the ovary tissue homogenates for each rat. Results In the ischemia-reperfusion with RA group, the epithelial cells are regularly regulated at the periphery, and the degenerative changes in preantral and antral follicle cells are reduced. Follicle cells and cells in the corpus luteum showed a decrease in vascular endothelial growth factor (VEGF) expression, while VEGF demonstrated a positive reaction in vascular endothelial cells and stromal cells. The TNF-α expression due to the decreased degenerative effect and inflammation was positive in the macrophage cells. The expression of caspase-3 as an apoptosis change was negative in antral follicle cells and granular cells around the antral follicle. Conclusion Different doses of RA may be useful in preventing ischemic damage after vascularization, inflammation, and apoptotic development after ischemia/reperfusion.


Sujets)
Animaux , Femelle , Rats , Maladies ovariennes , Lésion d'ischémie-reperfusion , Cinnamates , Facteur de croissance endothéliale vasculaire de type A , Depsides , Maladies ovariennes/traitement médicamenteux , Anomalie de torsion/traitement médicamenteux , Cinnamates/usage thérapeutique , Cinnamates/pharmacologie , Rat Wistar , Cellules endothéliales , Depsides/usage thérapeutique , Depsides/pharmacologie , Inflammation , Malonaldéhyde , Antioxydants
SÉLECTION CITATIONS
Détails de la recherche